Production (Stage)
Neuphoria Therapeutics Inc.
NEUP
$6.87
-$0.28-3.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.04M | 4.34M | 8.08M | 12.61M | 10.13M |
| Total Receivables | 24.60K | 35.60K | 116.00K | 126.90K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.90K | 18.50K | 231.10K | 458.80K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.09M | 4.40M | 8.43M | 13.19M | -- |
|
|
|||||
| Total Current Assets | 17.09M | 4.40M | 8.43M | 13.19M | -- |
| Net Property, Plant & Equipment | 126.80K | 152.20K | 199.40K | 219.00K | -- |
| Long-term Investments | 8.45M | 8.41M | 8.90M | 8.69M | -- |
| Goodwill | 8.45M | 8.41M | 8.90M | 8.69M | -- |
| Total Other Intangibles | 4.97M | 5.14M | 5.30M | 5.47M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 74.70K | 74.00K | 82.50K | 78.80K | -- |
| Total Assets | 30.71M | 18.17M | 22.92M | 27.65M | -- |
|
|
|||||
| Total Accounts Payable | 745.30K | 1.53M | 1.33M | 2.24M | -- |
| Total Accrued Expenses | 620.60K | 484.50K | 1.10M | 1.46M | -- |
| Short-term Debt | 31.40K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 121.70K | 118.50K | 129.90K | 122.00K | -- |
| Total Finance Division Other Current Liabilities | 33.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 33.00K | -- | -- | -- | -- |
| Total Current Liabilities | 1.55M | 2.13M | 2.55M | 3.83M | -- |
|
|
|||||
| Total Current Liabilities | 1.55M | 2.13M | 2.55M | 3.83M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 31.40K | -- | -- | -- | -- |
| Capital Leases | 19.30K | 49.80K | 89.50K | 117.60K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.14M | 2.24M | 3.21M | 6.21M | -- |
| Total Liabilities | 4.72M | 4.42M | 5.85M | 10.16M | -- |
|
|
|||||
| Common Stock & APIC | 199.37M | 198.19M | 198.28M | 198.48M | -- |
| Retained Earnings | -169.46M | -180.73M | -178.78M | -177.98M | -- |
| Treasury Stock & Other | -3.91M | -3.72M | -2.43M | -3.01M | -- |
| Total Common Equity | 26.00M | 13.75M | 17.07M | 17.49M | 19.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.00M | 13.75M | 17.07M | 17.49M | 19.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.00M | 13.75M | 17.07M | 17.49M | 19.79M |
|
|
|||||